Introducing the first FDA approved rapid point-of-care test that detects both HIV-1/2 antibodies and free HIV-1 p24 antigen. This 4th generation test has the ability to identify HIV earlier than 2nd and 3rd generation antibody-only tests.1 It enables health care providers to diagnose HIV infection earlier allowing individuals to seek medical care sooner.
Now CLIA-Waived for fingerstick whole blood!
Only available in the US.
1. Masciotra, S, et al. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast. J Clin Virol 2013: Published online 05 August 2013. DOI: 10.1016/j.jcv.2013.07.002 http://www.journalofclinicalvirology.com/article/S1386-6532(13)00277-1/abstract
2. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibodyseroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17(13):1871-1879.
*Average shelf life received by customer (product has a 15 month shelf life from date of manufacture)
**From date of manufacture
Based on your current location, the content on this page may not be relevant for your country.